Return-path: <response@response.hansonwade.com>
Envelope-to: amber@transocean.com
Delivery-date: Thu, 18 Dec 2014 05:49:14 -0800
Received: from e208.en25.com ([209.167.231.208]:59519)
	by vps.transocean.com with esmtp (Exim 4.82)
	(envelope-from <response@response.hansonwade.com>)
	id 1Y1bS5-0001PJ-Rn
	for amber@transocean.com; Thu, 18 Dec 2014 05:49:14 -0800
Received: from [10.4.1.10] ([10.4.1.10:52533] helo=P01INJECT019)
	by msm-mta04-tor6 (envelope-from <response@response.hansonwade.com>)
	(ecelerity 3.5.4.38585 r(Platform:3.5.4.0)) with ESMTP
	id 92/0C-15830-75BD2945; Thu, 18 Dec 2014 08:49:11 -0500
Message-ID: <56797cadafc44ad09a860d57f14606c6@2622>
X-Binding: 2622
X-elqPod: 0x04D4AA276AEFAC548AF4C2541180280C6E4E16410A533B620AAC2EC8FC2601D8
List-Unsubscribe: <http://s2622.t.en25.com/e/u?s=2622&elq=56797cad-afc4-4ad0-9a86-0d57f14606c6>
MIME-Version: 1.0
From: "Charlotte Paranby" <info@hansonwade.com>
To: amber@transocean.com
Reply-To: "Hanson Wade" <info@hansonwade.com>
Date: 18 Dec 2014 08:49:10 -0500
Subject: Break new ground with Real World Evidence
Content-Type: multipart/alternative;
 boundary=--boundary_737937_28067d47-bb54-4f0b-92ed-d2aef006531b
X-Spam-Status: No, score=
X-Spam-Score: 
X-Spam-Bar: 
X-Ham-Report: 
X-Spam-Flag: NO


----boundary_737937_28067d47-bb54-4f0b-92ed-d2aef006531b
Content-Type: text/plain; charset=utf-8
Content-Transfer-Encoding: base64
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----boundary_737937_28067d47-bb54-4f0b-92ed-d2aef006531b
Content-Type: text/html; charset=utf-8
Content-Transfer-Encoding: 7bit

<!DOCTYPE html>
<html>
<head>
<!-- StartSystemHeader --><style>body{   } a img{border: none;}.ReadMsgBody { width: 100%;}.ExternalClass {width: 100%;}</style><!-- EndSystemheader --></head>
<body style=""><table align="left" width="7" height="3">
<tbody>
<tr>
<td align="centre"><br></td></tr></tbody></table><br>
 <table width="100%" border="0" cellspacing="0" cellpadding="0" class="email-body-wrapper"><tr><td align="center" height="0"></td></tr><tr><td>
<table cellspacing="0" cellpadding="0" border="0" bordercollapse="collapse" width="600" align="left" id="sc3258" style="table-layout: auto"><tr><td align="left" valign="top" width="5" height="3" id="empty0"></td><td align="left" valign="top" width="1" height="3" id="empty1"></td><td align="left" valign="top" width="369" height="3" id="empty2"></td><td align="left" valign="top" width="10" height="3" id="empty3"></td><td align="left" valign="top" width="200" height="3" id="empty4"></td>
<td align="left" valign="top" width="6" height="3" id="empty5"></td><td align="left" valign="top" width="5" height="3" id="empty6"></td><td align="left" valign="top" width="4" height="3" id="empty7"></td></tr><tr>
<td align="left" valign="top" width="5" height="72" id="empty8"></td><td valign="top" align="left" rowspan="1" colspan="6" width="591" height="72" id="view9" style="color: #000000; font-family: Arial; font-size: 12px; line-height: 18px; letter-spacing: 0px; word-wrap: break-word">
<div id="sc7286" class="sc-view hidden-border inline-styled-view editor-outline" style="left: 5px; width: 591px; top: 3px; height: 72px; color: #000000; font-family: Arial; font-size: 12px; line-height: 18px; letter-spacing: 0px; word-wrap: break-word; overflow: hidden"><div class="co-border-style" style="">

<table width="591" height="72" cellspacing="0" cellpadding="0" border="0" bordercollapse="collapse" class="co-style-table" style="color: #000000; font-family: Arial; font-size: 12px; line-height: 18px; letter-spacing: 0px; word-wrap: break-word; margin-top: 0px; margin-left: 0px; margin-right: 0px; margin-bottom: 0px"><tr><td valign="top" class="valign-able"><span class="remove-absolute">Dear Alison<span style="letter-spacing:0px;">,&nbsp;</span><div><br></div><div>In
 the run up to the holidays (which I'm sure we're all looking forward to!) I wanted to share with you a whitepaper that our Panel Partner <b style="color:rgb(150, 24, 150);">IMS Health</b> have put together.&nbsp;<br><div><div><br></div><div><br></div></div></div></span></td></tr></table></div></div></td><td align="left" valign="top" width="4" height="72" id="empty15"></td></tr><tr>
<td align="left" valign="top" width="5" height="5" id="empty16"></td>
<td align="left" valign="top" width="1" height="5" id="empty17"></td><td align="left" valign="top" width="369" height="5" id="empty18"></td><td align="left" valign="top" width="10" height="5" id="empty19"></td><td align="left" valign="top" width="200" height="5" id="empty20"></td><td align="left" valign="top" width="6" height="5" id="empty21"></td><td align="left" valign="top" width="5" height="5" id="empty22"></td><td align="left" valign="top" width="4" height="5" id="empty23"></td></tr><tr>
<td align="left" valign="top" width="5" height="5" id="empty24"></td><td align="left" valign="top" width="1" height="5" id="empty25"></td><td align="left" valign="top" width="369" height="5" id="empty26"></td><td align="left" valign="top" width="10" height="5" id="empty27"></td>
<td valign="top" align="left" rowspan="3" colspan="1" width="200" height="281" id="view28" style=""><div id="sc7291" class="sc-view" style="left: 385px; width: 200px; top: 80px; height: 281px; overflow: hidden">
<div class="co-border-style" style="border-width: 2px; border-style: none"><table width="200" height="281" cellspacing="0" cellpadding="0" border="0" bordercollapse="collapse" class="co-style-table" style="margin-top: 0px; margin-left: 0px; margin-right: 0px; margin-bottom: 0px"><tr><td valign="top" class="valign-able">
<a href="http://bigdatapharma-europe.com/library?utm_campaign=BDP-4824-INT-EM8-IMS%20Health%20content&utm_medium=email&utm_source=Eloqua&elq=56797cadafc44ad09a860d57f14606c6&elqCampaignId=8149" title="">
<img elqhref="http://bigdatapharma-europe.com/library" elqtitle="" width="200" height="281" src="http://img.en25.com/EloquaImages/clients/HansonWadeLtd/{8284ad9a-9270-44ba-ae0a-8b5a43c4f678}_IMS_email.png" title="" alt="" id="sc7293" class="sc-view sc-image-view editor-outline sc-regular-size" style="display: block; cursor: pointer"></a></td></tr></table></div>
</div></td><td align="left" valign="top" width="6" height="5" id="empty29"></td><td align="left" valign="top" width="5" height="5" id="empty30">
</td><td align="left" valign="top" width="4" height="5" id="empty31"></td></tr><tr><td align="left" valign="top" width="5" height="272" id="empty32"></td><td valign="top" align="left" rowspan="1" colspan="2" width="370" height="272" id="view33" style="color: #000000; font-family: Arial; font-size: 12px; line-height: 18px; letter-spacing: 0px; word-wrap: break-word">
<div id="sc7302" class="sc-view hidden-border inline-styled-view editor-outline" style="left: 5px; width: 370px; top: 85px; height: 272px; color: #000000; font-family: Arial; font-size: 12px; line-height: 18px; letter-spacing: 0px; word-wrap: break-word; overflow: hidden"><div class="co-border-style" style="">

<table width="370" height="272" cellspacing="0" cellpadding="0" border="0" bordercollapse="collapse" class="co-style-table" style="color: #000000; font-family: Arial; font-size: 12px; line-height: 18px; letter-spacing: 0px; word-wrap: break-word; margin-top: 0px; margin-left: 0px; margin-right: 0px; margin-bottom: 0px"><tr><td valign="top" class="valign-able"><span class="remove-absolute">'<b>
<a href="http://bigdatapharma-europe.com/library?utm_campaign=BDP-4824-INT-EM8-IMS%20Health%20content&utm_medium=email&utm_source=Eloqua&elq=56797cadafc44ad09a860d57f14606c6&elqCampaignId=8149"><i>Breaking New Ground with RWE: How Some Pharmacos are Poised to Realize a $1 Billion Opportunity</i></a></b>' covers the recent investment by the pharma industry into Real World Evidence (RWE).&nbsp;<div><br></div><div>Differential success rates<span style="letter-spacing:0px;">&nbsp;have

 been observed, with little consensus on best practice or value potential, and the most successful companies have realised substantial value across the product lifecycle through RWE platforms and these RWE leaders are poised to capture sustained value.</span><div><div><br></div><div><b><a href="http://bigdatapharma-europe.com/library?utm_campaign=BDP-4824-INT-EM8-IMS%20Health%20content&utm_medium=email&utm_source=Eloqua&elq=56797cadafc44ad09a860d57f14606c6&elqCampaignId=8149">Download
 your own personal copy</a></b> and discover the <b>4 golden principles for RWE,</b> where companies can stumble and how to make sure you <b>gain a competitive advantage</b> with RWE.</div></div><div><br></div></div></span></td></tr></table></div></div></td><td align="left" valign="top" width="10" height="272" id="empty35"></td><td align="left" valign="top" width="6" height="272" id="empty37"></td><td align="left" valign="top" width="5" height="272" id="empty38"></td>
<td align="left" valign="top" width="4" height="272" id="empty39"></td></tr>
<tr><td align="left" valign="top" width="5" height="4" id="empty40"></td><td align="left" valign="top" width="1" height="4" id="empty41"></td><td align="left" valign="top" width="369" height="4" id="empty42"></td><td align="left" valign="top" width="10" height="4" id="empty43"></td><td align="left" valign="top" width="6" height="4" id="empty45"></td><td align="left" valign="top" width="5" height="4" id="empty46"></td>
<td align="left" valign="top" width="4" height="4" id="empty47"></td></tr><tr><td align="left" valign="top" width="5" height="9" id="empty48"></td><td align="left" valign="top" width="1" height="9" id="empty49"></td><td align="left" valign="top" width="369" height="9" id="empty50"></td><td align="left" valign="top" width="10" height="9" id="empty51"></td><td align="left" valign="top" width="200" height="9" id="empty52"></td>
<td align="left" valign="top" width="6" height="9" id="empty53"></td>
<td align="left" valign="top" width="5" height="9" id="empty54"></td><td align="left" valign="top" width="4" height="9" id="empty55"></td></tr><tr><td align="left" valign="top" width="5" height="270" id="empty56"></td><td align="left" valign="top" width="1" height="270" id="empty57"></td><td valign="top" align="left" rowspan="1" colspan="4" width="585" height="270" id="view58" style="color: #000000; font-family: Arial; font-size: 12px; line-height: 18px; letter-spacing: 0px; word-wrap: break-word">
<div id="sc7306" class="sc-view hidden-border inline-styled-view editor-outline" style="left: 6px; width: 585px; top: 370px; height: 270px; color: #000000; font-family: Arial; font-size: 12px; line-height: 18px; letter-spacing: 0px; word-wrap: break-word; overflow: hidden"><div class="co-border-style" style="">

<table width="585" height="270" cellspacing="0" cellpadding="0" border="0" bordercollapse="collapse" class="co-style-table" style="color: #000000; font-family: Arial; font-size: 12px; line-height: 18px; letter-spacing: 0px; word-wrap: break-word; margin-top: 0px; margin-left: 0px; margin-right: 0px; margin-bottom: 0px"><tr><td valign="top" class="valign-able"><span class="remove-absolute"><b>IMS Health</b>'s Peter Stephens, <b>Director of Public Health Affairs</b>,
 North Europe and Africa, will also be joining a panel on ' <b style="color:rgb(150, 24, 150);">How Does Privacy Affect Big Data? Who Owns the Data and who Profits from It?</b>' on day 2 of Big Data in Pharma Europe (find out what the full session will cover <b><a href="http://bigdatapharma-europe.com/download-brochure?utm_campaign=BDP-4824-INT-EM8-IMS%20Health%20content&utm_medium=email&utm_source=Eloqua&elq=56797cadafc44ad09a860d57f14606c6&elqCampaignId=8149">here</a></b>). &nbsp;<div><br></div><div>If

 you'd like to join us, there's still time to confirm your place <b><a href="http://bigdatapharma-europe.com/register?utm_campaign=BDP-4824-INT-EM8-IMS%20Health%20content&utm_medium=email&utm_source=Eloqua&elq=56797cadafc44ad09a860d57f14606c6&elqCampaignId=8149">online</a></b>.&nbsp;</div><div><br></div><div>Otherwise, I hope you enjoy reading <b>
<a href="http://bigdatapharma-europe.com/library?utm_campaign=BDP-4824-INT-EM8-IMS%20Health%20content&utm_medium=email&utm_source=Eloqua&elq=56797cadafc44ad09a860d57f14606c6&elqCampaignId=8149">this whitepaper</a></b> over your lunch or a cup of coffee this afternoon.</div><div><br></div><div>Best,&nbsp;</div><div><br></div><div>Charlotte</div><div><br></div><div><b>Charlotte Parnaby</b></div><div><b>Marketing Manager - Big DiP&nbsp;</b></div><div><b>Hanson Wade</b></div></span></td></tr></table></div>
</div></td><td align="left" valign="top" width="5" height="270" id="empty62"></td><td align="left" valign="top" width="4" height="270" id="empty63"></td></tr><tr><td align="left" valign="top" width="5" height="10" id="empty64"></td><td align="left" valign="top" width="1" height="10" id="empty65"></td>
<td align="left" valign="top" width="369" height="10" id="empty66"></td><td align="left" valign="top" width="10" height="10" id="empty67"></td>
<td align="left" valign="top" width="200" height="10" id="empty68"></td><td align="left" valign="top" width="6" height="10" id="empty69"></td><td align="left" valign="top" width="5" height="10" id="empty70"></td><td align="left" valign="top" width="4" height="10" id="empty71"></td></tr></table></td></tr><tr><td align="center" height="0"></td></tr></table> 
<font style="font-family: Arial; font-size: 10px;" face="">If
 you no longer wish to receive updates about this meeting <a title="Stop receiving emails about this meeting" href="http://s2622.t.en25.com/e/cu?s=2622&elqc=292&elq=56797cadafc44ad09a860d57f14606c6">click here</a></font><br><font style="font-family: Arial; font-size: 10px;" face="">To unsubscribe from all further email communication from Hanson Wade <a title="Opt out of all Hanson Wade email communication" href="http://s2622.t.en25.com/e/u?s=2622&elq=56797cadafc44ad09a860d57f14606c6">click here</a>.
 </font><br><font style="font-family: Arial; font-size: 10px;" face="">This email was sent to you at: </font><font style="font-family: Arial; font-size: 10px;" face="">amber@transocean.com</font><br><font style="font-family: Arial; font-size: 10px;" face=""><a title="Hanson Wade" href="http://www.hansonwade.com/?utm_campaign=BDP-4824-INT-EM8-IMS%20Health%20content&utm_medium=email&utm_source=Eloqua&elq=56797cadafc44ad09a860d57f14606c6&elqCampaignId=8149">Hanson Wade</a>
 respects your <a title="Privacy Policy" href="http://hansonwade.com/privacy?utm_campaign=BDP-4824-INT-EM8-IMS%20Health%20content&utm_medium=email&utm_source=Eloqua&elq=56797cadafc44ad09a860d57f14606c6&elqCampaignId=8149">privacy</a></font><br><font style="font-family: Arial; font-size: 10px;">&copy; 2012, Hanson Wade, 52 Grosvenor Gardens, London, SW1W 0AU</font>



<img src='http://s2622.t.en25.com/e/FooterImages/FooterImage1?elq=56797cadafc44ad09a860d57f14606c6&siteid=2622' border=0 width=1px height=1px></body></html>
----boundary_737937_28067d47-bb54-4f0b-92ed-d2aef006531b--


